suPARnostic
Clinical Implementation of suPARnostic® TurbiLatex at University Hospital of Montpellier, France
suPARnostic® will now be available for clinical decision making in the University Hospital of Montpellier, France.
It will be the first hospital in the world to run suPARnostic® TurbiLatex at the Roche cobas 8000 system.
suPARnostic® launch on QIAGEN´s automated Lateral Flow aLF platform
ViroGates and QIAGEN announces a partnership to launch suPARnostic® Quick Triage on QIAGEN’s automated Lateral Flow (aLF) platform.
New Employees at ViroGates
ViroGates is expanding and has employed yet another two employees; new Global Partner Director and new CFO.
Availability of suPAR in emergency departments may improve risk stratification
New abstract published in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine;
"Availability of suPAR in emergency departments may improve risk stratification: A secondary analysis of the TRIAGE III trial" by Schultz M et al.
